Brain implant to help restore speech after stroke-related aphasia
Tests a brain-computer interface in stroke survivors who have trouble speaking.
Plain-language title generated from the registry record
Registry title: Restoring Speech With an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia (BG-Aphasia-02)
Key facts
- Where
- Sacramento, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07918768, who can take part
Where in United States
- University of California - DavisSacramento, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Leigh R. Hochberg, MD, PhD.
- Trial code
- NCT07918768
- Record updated
- 5 November 2026
- Original description
In this study, the investigators aim to continue the development of a brain-computer interface (BCI) to help restore speech for stroke survivors with agrammatic aphasia, a language disorder that affects the ability to speak.Read full original descriptionShow less
Restoring Speech With an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia
In this study, the investigators aim to continue the development of a brain-computer interface (BCI) to help restore speech for stroke survivors with agrammatic aphasia, a language disorder that affects the ability to speak.
Inclusion: Inclusion Criteria:; Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis, or other motor neuron disorders; Complete or incomplete tetraplegia (quadriplegia); Prior enrollment in BrainGate2 clinical trial (NCT00912041).
Exclusion: Chronic oral or intravenous steroids or immunosuppressive therapy; Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses; Other serious disease or disorder that could seriously affect ability to participate in the study; (There are additional exclusion criteria).